Morningstar

Zoetis Inc Class A ZOE Stock

Stock Price as of EUR

Company Profile ZOE

Business Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Contact
10 Sylvan Way, Parsippany, NJ 07054
T +1 973 822-7000
steve.frank@zoetis.com opens in a new tab
www.zoetis.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Dec 31, 2025
Employees
13,800
As of Dec 31, 2024

Sustainability

ESG Risk Rating Assessment
Highest Controversy Level (1 = Low, 5 = Severe)
Moderate
Incidents: Customer
ESG Risk Rating
15.08
Low
Negligible
0–9.99
Low
10–19.99
Medium
20–29.99
High
30–39.99
Severe
40+
Highest Controversy Level (1 = Low, 5 = Severe)
Incidents: Customer
Top Material ESG Issues
Product Governance
Overall
Business Ethics
Overall
Human Capital
Overall
ESG Risk Rating is as of Jun 04, 2025. Highest Controversy Level is as of Jul 08, 2025. Sustainalytics Subindustry: Pharmaceuticals. Sustainalytics provides Morningstar with company ESG ratings and metrics on a monthly basis and as such, the ratings in Morningstar may not necessarily reflect current Sustainalytics’ scores for the company. For the most up to date rating and more information, please visit: sustainalytics.com/esg-ratings/ opens in a new tab.

© Morningstar 2025. All Rights Reserved. The data and analyses herein do not constitute investment advice; is provided solely for informational purposes; is not an offer to buy/sell a security; and is not warranted to be correct, complete, or accurate. Morningstar is not responsible for any trading decisions, damages or losses resulting from, or related to, the data and analyses or their use. Financial Professionals: This report may not meet all applicable presentation and/or disclosure standards to which you are subject to by a regulator and may need to be supplemented with another report or additional data and/or disclosures. Review carefully before sharing this report and contact your Compliance team with any questions. The ESG-related information, methodologies, tool, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.